Electrophysiologic and Biochemical Mechanisms Underlying Malignant Ventricular Arrhythmias during Early Myocardial Ischemia
Stephen M. Pogwizd, Peter B. Corr
Abstract
Stephen M. Pogwizd, Peter B. Corr
Abstract
Sudden cardiac death accounts for over 300,000 deaths per year in the United States alone [111]. It most often occurs in the setting of diffuse coronary artery disease [9], and in about 25% of cases of sudden cardiac death, the event is the initial presentation of coronary disease [87]. Death is most often due to malignant ventricular arrhythmias including complex premature ventricular complexes or ventricular tachycardia which culminate in the development of ventricular fibrillation [23].
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Sudden cardiac death accounts for over 300,000 deaths per year in the United States alone [111]. It most often occurs in the setting of diffuse coronary artery disease [9], and in about 25% of cases of sudden cardiac death, the event is the initial presentation of coronary disease [87]. Death is most often due to malignant ventricular arrhythmias including complex premature ventricular complexes or ventricular tachycardia which culminate in the development of ventricular fibrillation [23].
Key concepts: Cardiology, Ventricular fibrillation, Medicine, Internal medicine, Ventricular tachycardia, Coronary artery disease, Sudden cardiac death, Fibrillation